nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—ESR1—Tamoxifen—pancreatic cancer	0.0848	0.137	CbGbCtD
Melatonin—CYP1B1—Tamoxifen—pancreatic cancer	0.0848	0.137	CbGbCtD
Melatonin—CYP1B1—Erlotinib—pancreatic cancer	0.0721	0.117	CbGbCtD
Melatonin—CYP19A1—Tamoxifen—pancreatic cancer	0.0687	0.111	CbGbCtD
Melatonin—CYP1B1—Docetaxel—pancreatic cancer	0.0477	0.0773	CbGbCtD
Melatonin—CYP1A1—Dacarbazine—pancreatic cancer	0.0468	0.0758	CbGbCtD
Melatonin—CYP1A1—Tamoxifen—pancreatic cancer	0.0372	0.0603	CbGbCtD
Melatonin—CYP1B1—Doxorubicin—pancreatic cancer	0.0356	0.0576	CbGbCtD
Melatonin—CYP1A1—Erlotinib—pancreatic cancer	0.0316	0.0513	CbGbCtD
Melatonin—MPO—superior mesenteric artery—pancreatic cancer	0.0288	0.372	CbGeAlD
Melatonin—CYP1A2—Dacarbazine—pancreatic cancer	0.0209	0.0339	CbGbCtD
Melatonin—CYP2C19—Tamoxifen—pancreatic cancer	0.018	0.0292	CbGbCtD
Melatonin—CYP1A2—Tamoxifen—pancreatic cancer	0.0166	0.0269	CbGbCtD
Melatonin—CYP2C9—Tamoxifen—pancreatic cancer	0.015	0.0243	CbGbCtD
Melatonin—CYP1A2—Erlotinib—pancreatic cancer	0.0141	0.0229	CbGbCtD
Melatonin—CYP1A2—Fluorouracil—pancreatic cancer	0.0122	0.0198	CbGbCtD
Melatonin—CYP2C9—Fluorouracil—pancreatic cancer	0.011	0.0179	CbGbCtD
Melatonin—MTNR1B—islet of Langerhans—pancreatic cancer	0.00653	0.0842	CbGeAlD
Melatonin—CALR—gall bladder—pancreatic cancer	0.0052	0.0671	CbGeAlD
Melatonin—EPX—digestive system—pancreatic cancer	0.00461	0.0594	CbGeAlD
Melatonin—ASMT—digestive system—pancreatic cancer	0.00382	0.0493	CbGeAlD
Melatonin—IDO1—digestive system—pancreatic cancer	0.00349	0.045	CbGeAlD
Melatonin—CALR—islet of Langerhans—pancreatic cancer	0.00341	0.044	CbGeAlD
Melatonin—CALR—pancreas—pancreatic cancer	0.0024	0.0309	CbGeAlD
Melatonin—CALR—digestive system—pancreatic cancer	0.00205	0.0264	CbGeAlD
Melatonin—NQO2—islet of Langerhans—pancreatic cancer	0.00192	0.0248	CbGeAlD
Melatonin—CALM2—gall bladder—pancreatic cancer	0.00159	0.0206	CbGeAlD
Melatonin—NQO2—pancreas—pancreatic cancer	0.00135	0.0174	CbGeAlD
Melatonin—CALM3—islet of Langerhans—pancreatic cancer	0.00133	0.0172	CbGeAlD
Melatonin—CALM2—islet of Langerhans—pancreatic cancer	0.00105	0.0135	CbGeAlD
Melatonin—MPO—pancreas—pancreatic cancer	0.00104	0.0134	CbGeAlD
Melatonin—CALM1—islet of Langerhans—pancreatic cancer	0.00104	0.0134	CbGeAlD
Melatonin—CALM3—pancreas—pancreatic cancer	0.000936	0.0121	CbGeAlD
Melatonin—MPO—digestive system—pancreatic cancer	0.000889	0.0115	CbGeAlD
Melatonin—CALM2—pancreas—pancreatic cancer	0.000735	0.00948	CbGeAlD
Melatonin—CALM1—pancreas—pancreatic cancer	0.000731	0.00943	CbGeAlD
Melatonin—CYP1B1—digestive system—pancreatic cancer	0.000679	0.00876	CbGeAlD
Melatonin—ESR1—digestive system—pancreatic cancer	0.000631	0.00814	CbGeAlD
Melatonin—CALM2—digestive system—pancreatic cancer	0.000627	0.00809	CbGeAlD
Melatonin—CALM1—digestive system—pancreatic cancer	0.000625	0.00806	CbGeAlD
Melatonin—CYP2C19—digestive system—pancreatic cancer	0.000596	0.00768	CbGeAlD
Melatonin—CYP1A2—digestive system—pancreatic cancer	0.000487	0.00628	CbGeAlD
Melatonin—CYP1A1—digestive system—pancreatic cancer	0.00048	0.00619	CbGeAlD
Melatonin—CYP2C9—digestive system—pancreatic cancer	0.000462	0.00596	CbGeAlD
Melatonin—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000215	0.00143	CcSEcCtD
Melatonin—Dizziness—Tamoxifen—pancreatic cancer	0.000215	0.00143	CcSEcCtD
Melatonin—Affect lability—Epirubicin—pancreatic cancer	0.000214	0.00143	CcSEcCtD
Melatonin—Migraine—Epirubicin—pancreatic cancer	0.000214	0.00143	CcSEcCtD
Melatonin—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.000213	0.00142	CcSEcCtD
Melatonin—Dizziness—Erlotinib—pancreatic cancer	0.000213	0.00142	CcSEcCtD
Melatonin—Eye disorder—Docetaxel—pancreatic cancer	0.000208	0.00139	CcSEcCtD
Melatonin—Insomnia—Irinotecan—pancreatic cancer	0.000207	0.00138	CcSEcCtD
Melatonin—Cardiac disorder—Docetaxel—pancreatic cancer	0.000207	0.00138	CcSEcCtD
Melatonin—Vomiting—Tamoxifen—pancreatic cancer	0.000207	0.00138	CcSEcCtD
Melatonin—Mood swings—Epirubicin—pancreatic cancer	0.000206	0.00137	CcSEcCtD
Melatonin—Paraesthesia—Irinotecan—pancreatic cancer	0.000206	0.00137	CcSEcCtD
Melatonin—Lethargy—Doxorubicin—pancreatic cancer	0.000205	0.00137	CcSEcCtD
Melatonin—Hypersensitivity—Sunitinib—pancreatic cancer	0.000205	0.00137	CcSEcCtD
Melatonin—Rash—Tamoxifen—pancreatic cancer	0.000205	0.00137	CcSEcCtD
Melatonin—Dermatitis—Tamoxifen—pancreatic cancer	0.000205	0.00137	CcSEcCtD
Melatonin—Vomiting—Erlotinib—pancreatic cancer	0.000204	0.00136	CcSEcCtD
Melatonin—Somnolence—Irinotecan—pancreatic cancer	0.000204	0.00136	CcSEcCtD
Melatonin—Headache—Tamoxifen—pancreatic cancer	0.000203	0.00136	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000203	0.00136	CcSEcCtD
Melatonin—Rash—Erlotinib—pancreatic cancer	0.000203	0.00135	CcSEcCtD
Melatonin—Dermatitis—Erlotinib—pancreatic cancer	0.000202	0.00135	CcSEcCtD
Melatonin—Angiopathy—Docetaxel—pancreatic cancer	0.000202	0.00135	CcSEcCtD
Melatonin—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000202	0.00135	CcSEcCtD
Melatonin—Insomnia—Gemcitabine—pancreatic cancer	0.000202	0.00135	CcSEcCtD
Melatonin—Dyspepsia—Irinotecan—pancreatic cancer	0.000202	0.00135	CcSEcCtD
Melatonin—Immune system disorder—Docetaxel—pancreatic cancer	0.000201	0.00134	CcSEcCtD
Melatonin—Headache—Erlotinib—pancreatic cancer	0.000201	0.00134	CcSEcCtD
Melatonin—Pain in extremity—Doxorubicin—pancreatic cancer	0.000201	0.00134	CcSEcCtD
Melatonin—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000201	0.00134	CcSEcCtD
Melatonin—Paraesthesia—Gemcitabine—pancreatic cancer	0.0002	0.00134	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.0002	0.00133	CcSEcCtD
Melatonin—Asthenia—Sunitinib—pancreatic cancer	0.0002	0.00133	CcSEcCtD
Melatonin—Dry skin—Epirubicin—pancreatic cancer	0.000199	0.00133	CcSEcCtD
Melatonin—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000199	0.00132	CcSEcCtD
Melatonin—Insomnia—Fluorouracil—pancreatic cancer	0.000199	0.00132	CcSEcCtD
Melatonin—Somnolence—Gemcitabine—pancreatic cancer	0.000198	0.00132	CcSEcCtD
Melatonin—Migraine—Doxorubicin—pancreatic cancer	0.000198	0.00132	CcSEcCtD
Melatonin—Affect lability—Doxorubicin—pancreatic cancer	0.000198	0.00132	CcSEcCtD
Melatonin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000198	0.00132	CcSEcCtD
Melatonin—Fatigue—Irinotecan—pancreatic cancer	0.000198	0.00132	CcSEcCtD
Melatonin—Paraesthesia—Fluorouracil—pancreatic cancer	0.000197	0.00132	CcSEcCtD
Melatonin—Pruritus—Sunitinib—pancreatic cancer	0.000197	0.00131	CcSEcCtD
Melatonin—Breast disorder—Epirubicin—pancreatic cancer	0.000196	0.00131	CcSEcCtD
Melatonin—Pain—Irinotecan—pancreatic cancer	0.000196	0.00131	CcSEcCtD
Melatonin—Mental disorder—Docetaxel—pancreatic cancer	0.000195	0.0013	CcSEcCtD
Melatonin—Somnolence—Fluorouracil—pancreatic cancer	0.000195	0.0013	CcSEcCtD
Melatonin—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000194	0.0013	CcSEcCtD
Melatonin—Erythema—Docetaxel—pancreatic cancer	0.000194	0.0013	CcSEcCtD
Melatonin—Malnutrition—Docetaxel—pancreatic cancer	0.000194	0.0013	CcSEcCtD
Melatonin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000193	0.00129	CcSEcCtD
Melatonin—Nausea—Tamoxifen—pancreatic cancer	0.000193	0.00129	CcSEcCtD
Melatonin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000193	0.00129	CcSEcCtD
Melatonin—Fatigue—Gemcitabine—pancreatic cancer	0.000192	0.00128	CcSEcCtD
Melatonin—Gastritis—Epirubicin—pancreatic cancer	0.000192	0.00128	CcSEcCtD
Melatonin—Pain—Gemcitabine—pancreatic cancer	0.000191	0.00127	CcSEcCtD
Melatonin—Nausea—Erlotinib—pancreatic cancer	0.000191	0.00127	CcSEcCtD
Melatonin—Mood swings—Doxorubicin—pancreatic cancer	0.000191	0.00127	CcSEcCtD
Melatonin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000189	0.00126	CcSEcCtD
Melatonin—Back pain—Docetaxel—pancreatic cancer	0.000188	0.00125	CcSEcCtD
Melatonin—Pain—Fluorouracil—pancreatic cancer	0.000188	0.00125	CcSEcCtD
Melatonin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000187	0.00125	CcSEcCtD
Melatonin—Muscle spasms—Docetaxel—pancreatic cancer	0.000187	0.00125	CcSEcCtD
Melatonin—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000186	0.00124	CcSEcCtD
Melatonin—Dry skin—Doxorubicin—pancreatic cancer	0.000184	0.00123	CcSEcCtD
Melatonin—Dizziness—Sunitinib—pancreatic cancer	0.000184	0.00123	CcSEcCtD
Melatonin—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000184	0.00123	CcSEcCtD
Melatonin—Angina pectoris—Epirubicin—pancreatic cancer	0.000183	0.00122	CcSEcCtD
Melatonin—Breast disorder—Doxorubicin—pancreatic cancer	0.000182	0.00121	CcSEcCtD
Melatonin—Abdominal pain—Irinotecan—pancreatic cancer	0.000181	0.00121	CcSEcCtD
Melatonin—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.00018	0.0012	CcSEcCtD
Melatonin—Gastritis—Doxorubicin—pancreatic cancer	0.000178	0.00119	CcSEcCtD
Melatonin—Vomiting—Sunitinib—pancreatic cancer	0.000177	0.00118	CcSEcCtD
Melatonin—Rash—Sunitinib—pancreatic cancer	0.000175	0.00117	CcSEcCtD
Melatonin—Dermatitis—Sunitinib—pancreatic cancer	0.000175	0.00117	CcSEcCtD
Melatonin—Headache—Sunitinib—pancreatic cancer	0.000174	0.00116	CcSEcCtD
Melatonin—Syncope—Docetaxel—pancreatic cancer	0.000174	0.00116	CcSEcCtD
Melatonin—Leukopenia—Docetaxel—pancreatic cancer	0.000174	0.00116	CcSEcCtD
Melatonin—Palpitations—Docetaxel—pancreatic cancer	0.000172	0.00114	CcSEcCtD
Melatonin—Weight increased—Epirubicin—pancreatic cancer	0.000171	0.00114	CcSEcCtD
Melatonin—Loss of consciousness—Docetaxel—pancreatic cancer	0.000171	0.00114	CcSEcCtD
Melatonin—Angina pectoris—Doxorubicin—pancreatic cancer	0.000169	0.00113	CcSEcCtD
Melatonin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000169	0.00113	CcSEcCtD
Melatonin—Hypertension—Docetaxel—pancreatic cancer	0.000168	0.00112	CcSEcCtD
Melatonin—Infestation NOS—Epirubicin—pancreatic cancer	0.000168	0.00112	CcSEcCtD
Melatonin—Infestation—Epirubicin—pancreatic cancer	0.000168	0.00112	CcSEcCtD
Melatonin—Chest pain—Docetaxel—pancreatic cancer	0.000165	0.0011	CcSEcCtD
Melatonin—Arthralgia—Docetaxel—pancreatic cancer	0.000165	0.0011	CcSEcCtD
Melatonin—Nausea—Sunitinib—pancreatic cancer	0.000165	0.0011	CcSEcCtD
Melatonin—Asthenia—Irinotecan—pancreatic cancer	0.000164	0.0011	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000164	0.0011	CcSEcCtD
Melatonin—Stomatitis—Epirubicin—pancreatic cancer	0.000163	0.00109	CcSEcCtD
Melatonin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000162	0.00108	CcSEcCtD
Melatonin—Dry mouth—Docetaxel—pancreatic cancer	0.000162	0.00108	CcSEcCtD
Melatonin—Asthenia—Gemcitabine—pancreatic cancer	0.00016	0.00107	CcSEcCtD
Melatonin—Haematuria—Epirubicin—pancreatic cancer	0.00016	0.00107	CcSEcCtD
Melatonin—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000158	0.00106	CcSEcCtD
Melatonin—Weight increased—Doxorubicin—pancreatic cancer	0.000158	0.00106	CcSEcCtD
Melatonin—Pruritus—Gemcitabine—pancreatic cancer	0.000158	0.00105	CcSEcCtD
Melatonin—Infection—Docetaxel—pancreatic cancer	0.000157	0.00105	CcSEcCtD
Melatonin—Shock—Docetaxel—pancreatic cancer	0.000156	0.00104	CcSEcCtD
Melatonin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000155	0.00104	CcSEcCtD
Melatonin—Pruritus—Fluorouracil—pancreatic cancer	0.000155	0.00104	CcSEcCtD
Melatonin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000155	0.00104	CcSEcCtD
Melatonin—Infestation—Doxorubicin—pancreatic cancer	0.000155	0.00103	CcSEcCtD
Melatonin—Infestation NOS—Doxorubicin—pancreatic cancer	0.000155	0.00103	CcSEcCtD
Melatonin—Skin disorder—Docetaxel—pancreatic cancer	0.000154	0.00103	CcSEcCtD
Melatonin—Dizziness—Irinotecan—pancreatic cancer	0.000152	0.00101	CcSEcCtD
Melatonin—Stomatitis—Doxorubicin—pancreatic cancer	0.000151	0.00101	CcSEcCtD
Melatonin—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000149	0.000991	CcSEcCtD
Melatonin—Haematuria—Doxorubicin—pancreatic cancer	0.000148	0.000986	CcSEcCtD
Melatonin—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000148	0.000986	CcSEcCtD
Melatonin—Urethral disorder—Epirubicin—pancreatic cancer	0.000147	0.000984	CcSEcCtD
Melatonin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000147	0.000978	CcSEcCtD
Melatonin—Vomiting—Irinotecan—pancreatic cancer	0.000146	0.000972	CcSEcCtD
Melatonin—Dizziness—Fluorouracil—pancreatic cancer	0.000145	0.000969	CcSEcCtD
Melatonin—Rash—Irinotecan—pancreatic cancer	0.000144	0.000964	CcSEcCtD
Melatonin—Dermatitis—Irinotecan—pancreatic cancer	0.000144	0.000963	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000144	0.000963	CcSEcCtD
Melatonin—Headache—Irinotecan—pancreatic cancer	0.000144	0.000958	CcSEcCtD
Melatonin—Insomnia—Docetaxel—pancreatic cancer	0.000143	0.000956	CcSEcCtD
Melatonin—Paraesthesia—Docetaxel—pancreatic cancer	0.000142	0.000949	CcSEcCtD
Melatonin—Vomiting—Gemcitabine—pancreatic cancer	0.000142	0.000947	CcSEcCtD
Melatonin—Somnolence—Docetaxel—pancreatic cancer	0.000141	0.00094	CcSEcCtD
Melatonin—Rash—Gemcitabine—pancreatic cancer	0.000141	0.000939	CcSEcCtD
Melatonin—Dermatitis—Gemcitabine—pancreatic cancer	0.000141	0.000938	CcSEcCtD
Melatonin—Eye disorder—Epirubicin—pancreatic cancer	0.000141	0.000938	CcSEcCtD
Melatonin—Headache—Gemcitabine—pancreatic cancer	0.00014	0.000933	CcSEcCtD
Melatonin—Cardiac disorder—Epirubicin—pancreatic cancer	0.00014	0.000931	CcSEcCtD
Melatonin—Vomiting—Fluorouracil—pancreatic cancer	0.00014	0.000931	CcSEcCtD
Melatonin—Dyspepsia—Docetaxel—pancreatic cancer	0.000139	0.000931	CcSEcCtD
Melatonin—Rash—Fluorouracil—pancreatic cancer	0.000138	0.000923	CcSEcCtD
Melatonin—Dermatitis—Fluorouracil—pancreatic cancer	0.000138	0.000923	CcSEcCtD
Melatonin—Headache—Fluorouracil—pancreatic cancer	0.000138	0.000918	CcSEcCtD
Melatonin—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000137	0.000917	CcSEcCtD
Melatonin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000137	0.000913	CcSEcCtD
Melatonin—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000137	0.000913	CcSEcCtD
Melatonin—Fatigue—Docetaxel—pancreatic cancer	0.000137	0.000911	CcSEcCtD
Melatonin—Angiopathy—Epirubicin—pancreatic cancer	0.000136	0.000911	CcSEcCtD
Melatonin—Urethral disorder—Doxorubicin—pancreatic cancer	0.000136	0.00091	CcSEcCtD
Melatonin—Nausea—Irinotecan—pancreatic cancer	0.000136	0.000908	CcSEcCtD
Melatonin—Immune system disorder—Epirubicin—pancreatic cancer	0.000136	0.000906	CcSEcCtD
Melatonin—Pain—Docetaxel—pancreatic cancer	0.000135	0.000904	CcSEcCtD
Melatonin—Nausea—Gemcitabine—pancreatic cancer	0.000133	0.000885	CcSEcCtD
Melatonin—Mental disorder—Epirubicin—pancreatic cancer	0.000132	0.000879	CcSEcCtD
Melatonin—Erythema—Epirubicin—pancreatic cancer	0.000131	0.000874	CcSEcCtD
Melatonin—Malnutrition—Epirubicin—pancreatic cancer	0.000131	0.000874	CcSEcCtD
Melatonin—Nausea—Fluorouracil—pancreatic cancer	0.00013	0.00087	CcSEcCtD
Melatonin—Eye disorder—Doxorubicin—pancreatic cancer	0.00013	0.000868	CcSEcCtD
Melatonin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00013	0.000864	CcSEcCtD
Melatonin—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000129	0.000862	CcSEcCtD
Melatonin—Flatulence—Epirubicin—pancreatic cancer	0.000129	0.000861	CcSEcCtD
Melatonin—Tension—Epirubicin—pancreatic cancer	0.000128	0.000857	CcSEcCtD
Melatonin—Nervousness—Epirubicin—pancreatic cancer	0.000127	0.000849	CcSEcCtD
Melatonin—Back pain—Epirubicin—pancreatic cancer	0.000127	0.000845	CcSEcCtD
Melatonin—Angiopathy—Doxorubicin—pancreatic cancer	0.000126	0.000843	CcSEcCtD
Melatonin—Muscle spasms—Epirubicin—pancreatic cancer	0.000126	0.00084	CcSEcCtD
Melatonin—Immune system disorder—Doxorubicin—pancreatic cancer	0.000126	0.000839	CcSEcCtD
Melatonin—Abdominal pain—Docetaxel—pancreatic cancer	0.000125	0.000836	CcSEcCtD
Melatonin—Vision blurred—Epirubicin—pancreatic cancer	0.000123	0.000823	CcSEcCtD
Melatonin—Mental disorder—Doxorubicin—pancreatic cancer	0.000122	0.000814	CcSEcCtD
Melatonin—Erythema—Doxorubicin—pancreatic cancer	0.000121	0.000808	CcSEcCtD
Melatonin—Malnutrition—Doxorubicin—pancreatic cancer	0.000121	0.000808	CcSEcCtD
Melatonin—Agitation—Epirubicin—pancreatic cancer	0.00012	0.000803	CcSEcCtD
Melatonin—Flatulence—Doxorubicin—pancreatic cancer	0.000119	0.000797	CcSEcCtD
Melatonin—Tension—Doxorubicin—pancreatic cancer	0.000119	0.000793	CcSEcCtD
Melatonin—Nervousness—Doxorubicin—pancreatic cancer	0.000118	0.000785	CcSEcCtD
Melatonin—Vertigo—Epirubicin—pancreatic cancer	0.000118	0.000785	CcSEcCtD
Melatonin—Syncope—Epirubicin—pancreatic cancer	0.000117	0.000783	CcSEcCtD
Melatonin—Leukopenia—Epirubicin—pancreatic cancer	0.000117	0.000782	CcSEcCtD
Melatonin—Back pain—Doxorubicin—pancreatic cancer	0.000117	0.000782	CcSEcCtD
Melatonin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000117	0.000779	CcSEcCtD
Melatonin—Muscle spasms—Doxorubicin—pancreatic cancer	0.000116	0.000777	CcSEcCtD
Melatonin—Palpitations—Epirubicin—pancreatic cancer	0.000116	0.000772	CcSEcCtD
Melatonin—Loss of consciousness—Epirubicin—pancreatic cancer	0.000115	0.000768	CcSEcCtD
Melatonin—Vision blurred—Doxorubicin—pancreatic cancer	0.000114	0.000762	CcSEcCtD
Melatonin—Asthenia—Docetaxel—pancreatic cancer	0.000114	0.000758	CcSEcCtD
Melatonin—Hypertension—Epirubicin—pancreatic cancer	0.000113	0.000754	CcSEcCtD
Melatonin—Pruritus—Docetaxel—pancreatic cancer	0.000112	0.000748	CcSEcCtD
Melatonin—Chest pain—Epirubicin—pancreatic cancer	0.000111	0.000744	CcSEcCtD
Melatonin—Arthralgia—Epirubicin—pancreatic cancer	0.000111	0.000744	CcSEcCtD
Melatonin—Agitation—Doxorubicin—pancreatic cancer	0.000111	0.000743	CcSEcCtD
Melatonin—Anxiety—Epirubicin—pancreatic cancer	0.000111	0.000741	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000111	0.000739	CcSEcCtD
Melatonin—Dry mouth—Epirubicin—pancreatic cancer	0.000109	0.000727	CcSEcCtD
Melatonin—Vertigo—Doxorubicin—pancreatic cancer	0.000109	0.000726	CcSEcCtD
Melatonin—Syncope—Doxorubicin—pancreatic cancer	0.000109	0.000725	CcSEcCtD
Melatonin—Leukopenia—Doxorubicin—pancreatic cancer	0.000108	0.000724	CcSEcCtD
Melatonin—Palpitations—Doxorubicin—pancreatic cancer	0.000107	0.000714	CcSEcCtD
Melatonin—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000106	0.00071	CcSEcCtD
Melatonin—Infection—Epirubicin—pancreatic cancer	0.000106	0.000708	CcSEcCtD
Melatonin—Shock—Epirubicin—pancreatic cancer	0.000105	0.000701	CcSEcCtD
Melatonin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000105	0.000699	CcSEcCtD
Melatonin—Dizziness—Docetaxel—pancreatic cancer	0.000105	0.000699	CcSEcCtD
Melatonin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000105	0.000698	CcSEcCtD
Melatonin—Hypertension—Doxorubicin—pancreatic cancer	0.000105	0.000698	CcSEcCtD
Melatonin—Skin disorder—Epirubicin—pancreatic cancer	0.000104	0.000693	CcSEcCtD
Melatonin—Arthralgia—Doxorubicin—pancreatic cancer	0.000103	0.000688	CcSEcCtD
Melatonin—Chest pain—Doxorubicin—pancreatic cancer	0.000103	0.000688	CcSEcCtD
Melatonin—Anxiety—Doxorubicin—pancreatic cancer	0.000103	0.000686	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000102	0.000683	CcSEcCtD
Melatonin—Dry mouth—Doxorubicin—pancreatic cancer	0.000101	0.000673	CcSEcCtD
Melatonin—Vomiting—Docetaxel—pancreatic cancer	0.000101	0.000672	CcSEcCtD
Melatonin—Rash—Docetaxel—pancreatic cancer	9.99e-05	0.000667	CcSEcCtD
Melatonin—Dermatitis—Docetaxel—pancreatic cancer	9.98e-05	0.000666	CcSEcCtD
Melatonin—Headache—Docetaxel—pancreatic cancer	9.92e-05	0.000662	CcSEcCtD
Melatonin—Infection—Doxorubicin—pancreatic cancer	9.82e-05	0.000655	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	9.74e-05	0.00065	CcSEcCtD
Melatonin—Shock—Doxorubicin—pancreatic cancer	9.73e-05	0.000649	CcSEcCtD
Melatonin—Nervous system disorder—Doxorubicin—pancreatic cancer	9.7e-05	0.000647	CcSEcCtD
Melatonin—Thrombocytopenia—Doxorubicin—pancreatic cancer	9.68e-05	0.000646	CcSEcCtD
Melatonin—Insomnia—Epirubicin—pancreatic cancer	9.66e-05	0.000645	CcSEcCtD
Melatonin—Skin disorder—Doxorubicin—pancreatic cancer	9.6e-05	0.000641	CcSEcCtD
Melatonin—Paraesthesia—Epirubicin—pancreatic cancer	9.6e-05	0.00064	CcSEcCtD
Melatonin—Somnolence—Epirubicin—pancreatic cancer	9.5e-05	0.000634	CcSEcCtD
Melatonin—Nausea—Docetaxel—pancreatic cancer	9.41e-05	0.000628	CcSEcCtD
Melatonin—Dyspepsia—Epirubicin—pancreatic cancer	9.41e-05	0.000628	CcSEcCtD
Melatonin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	9.23e-05	0.000616	CcSEcCtD
Melatonin—Fatigue—Epirubicin—pancreatic cancer	9.21e-05	0.000615	CcSEcCtD
Melatonin—Pain—Epirubicin—pancreatic cancer	9.14e-05	0.00061	CcSEcCtD
Melatonin—Nabumetone—PTGS2—pancreatic cancer	9.06e-05	1	CrCbGaD
Melatonin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	9.01e-05	0.000601	CcSEcCtD
Melatonin—Insomnia—Doxorubicin—pancreatic cancer	8.94e-05	0.000597	CcSEcCtD
Melatonin—Paraesthesia—Doxorubicin—pancreatic cancer	8.88e-05	0.000592	CcSEcCtD
Melatonin—Somnolence—Doxorubicin—pancreatic cancer	8.79e-05	0.000587	CcSEcCtD
Melatonin—Gastrointestinal pain—Epirubicin—pancreatic cancer	8.74e-05	0.000583	CcSEcCtD
Melatonin—Dyspepsia—Doxorubicin—pancreatic cancer	8.7e-05	0.000581	CcSEcCtD
Melatonin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	8.54e-05	0.00057	CcSEcCtD
Melatonin—Fatigue—Doxorubicin—pancreatic cancer	8.52e-05	0.000569	CcSEcCtD
Melatonin—Pain—Doxorubicin—pancreatic cancer	8.45e-05	0.000564	CcSEcCtD
Melatonin—Abdominal pain—Epirubicin—pancreatic cancer	8.45e-05	0.000564	CcSEcCtD
Melatonin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	8.08e-05	0.000539	CcSEcCtD
Melatonin—Hypersensitivity—Epirubicin—pancreatic cancer	7.87e-05	0.000525	CcSEcCtD
Melatonin—Abdominal pain—Doxorubicin—pancreatic cancer	7.82e-05	0.000522	CcSEcCtD
Melatonin—Asthenia—Epirubicin—pancreatic cancer	7.67e-05	0.000512	CcSEcCtD
Melatonin—Pruritus—Epirubicin—pancreatic cancer	7.56e-05	0.000504	CcSEcCtD
Melatonin—Hypersensitivity—Doxorubicin—pancreatic cancer	7.28e-05	0.000486	CcSEcCtD
Melatonin—Asthenia—Doxorubicin—pancreatic cancer	7.09e-05	0.000473	CcSEcCtD
Melatonin—Dizziness—Epirubicin—pancreatic cancer	7.07e-05	0.000471	CcSEcCtD
Melatonin—Pruritus—Doxorubicin—pancreatic cancer	7e-05	0.000467	CcSEcCtD
Melatonin—Vomiting—Epirubicin—pancreatic cancer	6.79e-05	0.000453	CcSEcCtD
Melatonin—Rash—Epirubicin—pancreatic cancer	6.74e-05	0.00045	CcSEcCtD
Melatonin—Dermatitis—Epirubicin—pancreatic cancer	6.73e-05	0.000449	CcSEcCtD
Melatonin—Headache—Epirubicin—pancreatic cancer	6.69e-05	0.000447	CcSEcCtD
Melatonin—Dizziness—Doxorubicin—pancreatic cancer	6.54e-05	0.000436	CcSEcCtD
Melatonin—Nausea—Epirubicin—pancreatic cancer	6.35e-05	0.000424	CcSEcCtD
Melatonin—Vomiting—Doxorubicin—pancreatic cancer	6.29e-05	0.000419	CcSEcCtD
Melatonin—Rash—Doxorubicin—pancreatic cancer	6.23e-05	0.000416	CcSEcCtD
Melatonin—Dermatitis—Doxorubicin—pancreatic cancer	6.23e-05	0.000416	CcSEcCtD
Melatonin—Headache—Doxorubicin—pancreatic cancer	6.19e-05	0.000413	CcSEcCtD
Melatonin—Nausea—Doxorubicin—pancreatic cancer	5.87e-05	0.000392	CcSEcCtD
Melatonin—CALM2—Signaling Pathways—APOE—pancreatic cancer	4.76e-06	3.06e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—APOE—pancreatic cancer	4.76e-06	3.06e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—HRAS—pancreatic cancer	4.74e-06	3.04e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—HRAS—pancreatic cancer	4.74e-06	3.04e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PIK3CB—pancreatic cancer	4.7e-06	3.02e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PIK3CB—pancreatic cancer	4.7e-06	3.02e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CXCL8—pancreatic cancer	4.69e-06	3.01e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CD—pancreatic cancer	4.67e-06	3e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CTNNB1—pancreatic cancer	4.67e-06	3e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KDR—pancreatic cancer	4.67e-06	3e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KDR—pancreatic cancer	4.67e-06	3e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PTGS2—pancreatic cancer	4.66e-06	3e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PTGS2—pancreatic cancer	4.66e-06	3e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NFKBIA—pancreatic cancer	4.59e-06	2.95e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—APOE—pancreatic cancer	4.57e-06	2.94e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—PTEN—pancreatic cancer	4.55e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NOTCH1—pancreatic cancer	4.54e-06	2.92e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CD—pancreatic cancer	4.52e-06	2.9e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CD—pancreatic cancer	4.52e-06	2.9e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CTNNB1—pancreatic cancer	4.52e-06	2.9e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CTNNB1—pancreatic cancer	4.52e-06	2.9e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—AKT1—pancreatic cancer	4.5e-06	2.89e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CASP3—pancreatic cancer	4.48e-06	2.88e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CG—pancreatic cancer	4.44e-06	2.86e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—NRAS—pancreatic cancer	4.44e-06	2.86e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NFKBIA—pancreatic cancer	4.44e-06	2.85e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NFKBIA—pancreatic cancer	4.44e-06	2.85e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	4.43e-06	2.85e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—PTEN—pancreatic cancer	4.4e-06	2.83e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—PTEN—pancreatic cancer	4.4e-06	2.83e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NOTCH1—pancreatic cancer	4.39e-06	2.83e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NOTCH1—pancreatic cancer	4.39e-06	2.83e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EGF—pancreatic cancer	4.39e-06	2.82e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—TYMS—pancreatic cancer	4.38e-06	2.82e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CCND1—pancreatic cancer	4.37e-06	2.81e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—AKT1—pancreatic cancer	4.35e-06	2.8e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—AKT1—pancreatic cancer	4.35e-06	2.8e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.33e-06	2.78e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CTNNB1—pancreatic cancer	4.32e-06	2.78e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—AKT1—pancreatic cancer	4.32e-06	2.78e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CTNNB1—pancreatic cancer	4.31e-06	2.77e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CG—pancreatic cancer	4.3e-06	2.76e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CG—pancreatic cancer	4.3e-06	2.76e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—NRAS—pancreatic cancer	4.3e-06	2.76e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—NRAS—pancreatic cancer	4.3e-06	2.76e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EGF—pancreatic cancer	4.25e-06	2.73e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EGF—pancreatic cancer	4.25e-06	2.73e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MMP9—pancreatic cancer	4.24e-06	2.72e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—SRC—pancreatic cancer	4.22e-06	2.71e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PTEN—pancreatic cancer	4.21e-06	2.71e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PTEN—pancreatic cancer	4.2e-06	2.7e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—AKT1—pancreatic cancer	4.18e-06	2.69e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—AKT1—pancreatic cancer	4.18e-06	2.69e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CTNNB1—pancreatic cancer	4.17e-06	2.68e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CTNNB1—pancreatic cancer	4.17e-06	2.68e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—APOE—pancreatic cancer	4.17e-06	2.68e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	4.13e-06	2.65e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—SRC—pancreatic cancer	4.08e-06	2.62e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—SRC—pancreatic cancer	4.08e-06	2.62e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CB—pancreatic cancer	4.07e-06	2.62e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—STAT3—pancreatic cancer	4.07e-06	2.62e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PTEN—pancreatic cancer	4.06e-06	2.61e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PTEN—pancreatic cancer	4.06e-06	2.61e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—NRAS—pancreatic cancer	4.06e-06	2.61e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—EGFR—pancreatic cancer	4.05e-06	2.6e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTGS2—pancreatic cancer	4.03e-06	2.59e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PPARG—pancreatic cancer	3.98e-06	2.56e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PIK3CA—pancreatic cancer	3.97e-06	2.55e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.95e-06	2.54e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CB—pancreatic cancer	3.94e-06	2.53e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CB—pancreatic cancer	3.94e-06	2.53e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—STAT3—pancreatic cancer	3.94e-06	2.53e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—STAT3—pancreatic cancer	3.94e-06	2.53e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—NRAS—pancreatic cancer	3.93e-06	2.52e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—NRAS—pancreatic cancer	3.93e-06	2.52e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—EGFR—pancreatic cancer	3.92e-06	2.52e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—EGFR—pancreatic cancer	3.92e-06	2.52e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—SRC—pancreatic cancer	3.91e-06	2.51e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CD—pancreatic cancer	3.91e-06	2.51e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTGS2—pancreatic cancer	3.9e-06	2.51e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTGS2—pancreatic cancer	3.9e-06	2.51e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—SRC—pancreatic cancer	3.9e-06	2.5e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	3.86e-06	2.48e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTGS2—pancreatic cancer	3.83e-06	2.46e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PIK3CA—pancreatic cancer	3.82e-06	2.46e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—KRAS—pancreatic cancer	3.82e-06	2.46e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—pancreatic cancer	3.81e-06	2.45e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CD—pancreatic cancer	3.78e-06	2.43e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CD—pancreatic cancer	3.78e-06	2.43e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—SRC—pancreatic cancer	3.77e-06	2.42e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—SRC—pancreatic cancer	3.77e-06	2.42e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—STAT3—pancreatic cancer	3.77e-06	2.42e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	3.76e-06	2.42e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NRAS—pancreatic cancer	3.76e-06	2.42e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—STAT3—pancreatic cancer	3.76e-06	2.42e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—NRAS—pancreatic cancer	3.75e-06	2.41e-05	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—AKT1—pancreatic cancer	3.73e-06	2.4e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—KRAS—pancreatic cancer	3.7e-06	2.38e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—KRAS—pancreatic cancer	3.7e-06	2.38e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—EGFR—pancreatic cancer	3.7e-06	2.38e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—STAT3—pancreatic cancer	3.63e-06	2.34e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—STAT3—pancreatic cancer	3.63e-06	2.34e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.63e-06	2.33e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.63e-06	2.33e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—NRAS—pancreatic cancer	3.63e-06	2.33e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—NRAS—pancreatic cancer	3.63e-06	2.33e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—EGFR—pancreatic cancer	3.58e-06	2.3e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—EGFR—pancreatic cancer	3.58e-06	2.3e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—APOE—pancreatic cancer	3.56e-06	2.29e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTEN—pancreatic cancer	3.52e-06	2.26e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—PIK3CA—pancreatic cancer	3.51e-06	2.26e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MYC—pancreatic cancer	3.5e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—KRAS—pancreatic cancer	3.49e-06	2.25e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TGFB1—pancreatic cancer	3.49e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MYC—pancreatic cancer	3.49e-06	2.24e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—TGFB1—pancreatic cancer	3.48e-06	2.24e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EGFR—pancreatic cancer	3.42e-06	2.2e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—EGFR—pancreatic cancer	3.41e-06	2.2e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CB—pancreatic cancer	3.4e-06	2.19e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTEN—pancreatic cancer	3.4e-06	2.19e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTEN—pancreatic cancer	3.4e-06	2.19e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—PIK3CA—pancreatic cancer	3.4e-06	2.18e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—PIK3CA—pancreatic cancer	3.4e-06	2.18e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—KRAS—pancreatic cancer	3.38e-06	2.17e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—KRAS—pancreatic cancer	3.38e-06	2.17e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MYC—pancreatic cancer	3.38e-06	2.17e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MYC—pancreatic cancer	3.38e-06	2.17e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.37e-06	2.17e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—TGFB1—pancreatic cancer	3.37e-06	2.17e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—TGFB1—pancreatic cancer	3.37e-06	2.17e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTEN—pancreatic cancer	3.34e-06	2.15e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.31e-06	2.13e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—EGFR—pancreatic cancer	3.3e-06	2.12e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—EGFR—pancreatic cancer	3.3e-06	2.12e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CB—pancreatic cancer	3.29e-06	2.12e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CB—pancreatic cancer	3.29e-06	2.12e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CXCL8—pancreatic cancer	3.27e-06	2.1e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—HRAS—pancreatic cancer	3.25e-06	2.09e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—AKT1—pancreatic cancer	3.24e-06	2.09e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KRAS—pancreatic cancer	3.24e-06	2.08e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—KRAS—pancreatic cancer	3.23e-06	2.07e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	3.21e-06	2.07e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—PIK3CA—pancreatic cancer	3.21e-06	2.06e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CXCL8—pancreatic cancer	3.16e-06	2.03e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CXCL8—pancreatic cancer	3.16e-06	2.03e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	3.16e-06	2.03e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—HRAS—pancreatic cancer	3.14e-06	2.02e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—HRAS—pancreatic cancer	3.14e-06	2.02e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTGS2—pancreatic cancer	3.13e-06	2.01e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CASP3—pancreatic cancer	3.13e-06	2.01e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—AKT1—pancreatic cancer	3.12e-06	2.01e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—KRAS—pancreatic cancer	3.12e-06	2.01e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—KRAS—pancreatic cancer	3.12e-06	2.01e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—PIK3CA—pancreatic cancer	3.1e-06	2e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—PIK3CA—pancreatic cancer	3.1e-06	2e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PPARG—pancreatic cancer	3.1e-06	1.99e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCND1—pancreatic cancer	3.05e-06	1.96e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CASP3—pancreatic cancer	3.03e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CASP3—pancreatic cancer	3.03e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CTNNB1—pancreatic cancer	3.02e-06	1.94e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PIK3CA—pancreatic cancer	2.97e-06	1.91e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—HRAS—pancreatic cancer	2.97e-06	1.91e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PIK3CA—pancreatic cancer	2.96e-06	1.91e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MMP9—pancreatic cancer	2.96e-06	1.9e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCND1—pancreatic cancer	2.95e-06	1.9e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCND1—pancreatic cancer	2.95e-06	1.9e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTEN—pancreatic cancer	2.94e-06	1.89e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CTNNB1—pancreatic cancer	2.92e-06	1.88e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CTNNB1—pancreatic cancer	2.92e-06	1.88e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.88e-06	1.85e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—pancreatic cancer	2.88e-06	1.85e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—HRAS—pancreatic cancer	2.87e-06	1.85e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—HRAS—pancreatic cancer	2.87e-06	1.85e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—AKT1—pancreatic cancer	2.87e-06	1.85e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PIK3CA—pancreatic cancer	2.87e-06	1.84e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PIK3CA—pancreatic cancer	2.87e-06	1.84e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MMP9—pancreatic cancer	2.86e-06	1.84e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MMP9—pancreatic cancer	2.86e-06	1.84e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.86e-06	1.84e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTEN—pancreatic cancer	2.85e-06	1.83e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTEN—pancreatic cancer	2.85e-06	1.83e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.83e-06	1.82e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—AKT1—pancreatic cancer	2.78e-06	1.78e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—AKT1—pancreatic cancer	2.78e-06	1.78e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—HRAS—pancreatic cancer	2.75e-06	1.77e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—HRAS—pancreatic cancer	2.74e-06	1.76e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.73e-06	1.76e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SRC—pancreatic cancer	2.73e-06	1.75e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—pancreatic cancer	2.66e-06	1.71e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—HRAS—pancreatic cancer	2.65e-06	1.71e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—HRAS—pancreatic cancer	2.65e-06	1.71e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SRC—pancreatic cancer	2.64e-06	1.7e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SRC—pancreatic cancer	2.64e-06	1.7e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—STAT3—pancreatic cancer	2.63e-06	1.69e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NRAS—pancreatic cancer	2.62e-06	1.69e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—AKT1—pancreatic cancer	2.62e-06	1.69e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—pancreatic cancer	2.57e-06	1.65e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—pancreatic cancer	2.57e-06	1.65e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—STAT3—pancreatic cancer	2.54e-06	1.64e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—STAT3—pancreatic cancer	2.54e-06	1.64e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NRAS—pancreatic cancer	2.54e-06	1.63e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NRAS—pancreatic cancer	2.54e-06	1.63e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—AKT1—pancreatic cancer	2.54e-06	1.63e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—AKT1—pancreatic cancer	2.54e-06	1.63e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.49e-06	1.6e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CA—pancreatic cancer	2.48e-06	1.6e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.46e-06	1.58e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MYC—pancreatic cancer	2.44e-06	1.57e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.44e-06	1.57e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TGFB1—pancreatic cancer	2.44e-06	1.57e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—AKT1—pancreatic cancer	2.43e-06	1.56e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—AKT1—pancreatic cancer	2.42e-06	1.56e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CA—pancreatic cancer	2.4e-06	1.54e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CA—pancreatic cancer	2.4e-06	1.54e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EGFR—pancreatic cancer	2.39e-06	1.54e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MYC—pancreatic cancer	2.36e-06	1.52e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MYC—pancreatic cancer	2.36e-06	1.52e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TGFB1—pancreatic cancer	2.36e-06	1.52e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TGFB1—pancreatic cancer	2.36e-06	1.52e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	2.35e-06	1.51e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—AKT1—pancreatic cancer	2.34e-06	1.51e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—AKT1—pancreatic cancer	2.34e-06	1.51e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EGFR—pancreatic cancer	2.31e-06	1.49e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EGFR—pancreatic cancer	2.31e-06	1.49e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KRAS—pancreatic cancer	2.26e-06	1.45e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KRAS—pancreatic cancer	2.18e-06	1.4e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KRAS—pancreatic cancer	2.18e-06	1.4e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTEN—pancreatic cancer	2.13e-06	1.37e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CA—pancreatic cancer	2.08e-06	1.33e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—AKT1—pancreatic cancer	2.03e-06	1.3e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—pancreatic cancer	2.01e-06	1.29e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CA—pancreatic cancer	2.01e-06	1.29e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CA—pancreatic cancer	2.01e-06	1.29e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—AKT1—pancreatic cancer	1.96e-06	1.26e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—AKT1—pancreatic cancer	1.96e-06	1.26e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—pancreatic cancer	1.94e-06	1.25e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—pancreatic cancer	1.94e-06	1.25e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.93e-06	1.24e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—AKT1—pancreatic cancer	1.92e-06	1.24e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HRAS—pancreatic cancer	1.92e-06	1.23e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HRAS—pancreatic cancer	1.86e-06	1.19e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HRAS—pancreatic cancer	1.86e-06	1.19e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.76e-06	1.13e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—AKT1—pancreatic cancer	1.7e-06	1.09e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AKT1—pancreatic cancer	1.64e-06	1.05e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AKT1—pancreatic cancer	1.64e-06	1.05e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.57e-06	1.01e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.5e-06	9.65e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.44e-06	9.23e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.23e-06	7.89e-06	CbGpPWpGaD
